Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35,016 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment.
Vahdat S, Oermann EK, Collins SP, Yu X, Abedalthagafi M, Debrito P, Suy S, Yousefi S, Gutierrez CJ, Chang T, Banovac F, Anderson ED, Esposito G, Collins BT. Vahdat S, et al. Among authors: yu x. J Hematol Oncol. 2010 Feb 4;3:6. doi: 10.1186/1756-8722-3-6. J Hematol Oncol. 2010. PMID: 20132557 Free PMC article. Clinical Trial.
Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer.
Collins BT, Vahdat S, Erickson K, Collins SP, Suy S, Yu X, Zhang Y, Subramaniam D, Reichner CA, Sarikaya I, Esposito G, Yousefi S, Jamis-Dow C, Banovac F, Anderson ED. Collins BT, et al. Among authors: yu x. J Hematol Oncol. 2009 Jan 17;2:1. doi: 10.1186/1756-8722-2-1. J Hematol Oncol. 2009. PMID: 19149899 Free PMC article. Clinical Trial.
CyberKnife for hilar lung tumors: report of clinical response and toxicity.
Unger K, Ju A, Oermann E, Suy S, Yu X, Vahdat S, Subramaniam D, Harter KW, Collins SP, Dritschilo A, Anderson E, Collins BT. Unger K, et al. Among authors: yu x. J Hematol Oncol. 2010 Oct 22;3:39. doi: 10.1186/1756-8722-3-39. J Hematol Oncol. 2010. PMID: 20969774 Free PMC article.
Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer.
Oermann EK, Suy S, Hanscom HN, Kim JS, Lei S, Yu X, Zhang G, Ennis B, Rohan JP, Piel N, Sherer BA, Borum D, Chen VJ, Batipps GP, Constantinople NL, Dejter SW, Bandi G, Pahira J, McGeagh KG, Adams-Campbell L, Jha R, Dawson NA, Collins BT, Dritschilo A, Lynch JH, Collins SP. Oermann EK, et al. Among authors: yu x. J Hematol Oncol. 2011 Mar 27;4:12. doi: 10.1186/1756-8722-4-12. J Hematol Oncol. 2011. PMID: 21439088 Free PMC article.
Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach.
Gill B, Oermann E, Ju A, Suy S, Yu X, Rabin J, Kalhorn C, Nair MN, Voyadzis JM, Unger K, Collins SP, Harter KW, Collins BT. Gill B, et al. Among authors: yu x. Front Oncol. 2012 Apr 26;2:39. doi: 10.3389/fonc.2012.00039. eCollection 2012. Front Oncol. 2012. PMID: 22645718 Free PMC article.
35,016 results
You have reached the last available page of results. Please see the User Guide for more information.